GW Pharmaceuticals

Latest stories

1d
KETV 7 Omaha
UNMC launches study of medical cannabisspring of 2015 to get Epidiolex, a plant-based pharmaceutical formulation of pu
UNMC launches study of medical cannabis
KETV 7 Omaha / Posted yesterday
spring of 2015 to get Epidiolex, a plant-based pharmaceutical formulation of pure cannabidiol, from United Kingdom-based GW Pharmaceuticals. Lining up the legal supply led to support from Gov. Pete Ricketts, who then signed the bill authorizing... Read more
3d
ABC Action News Tampa Bay
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugsand 55 years old and took Epidiolex in addition to their other anti-epileptic m
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugs
ABC Action News Tampa Bay / Posted 3 days ago
and 55 years old and took Epidiolex in addition to their other anti-epileptic medication. The company that makes the drug, GW Pharmaceuticals, told outlets it will likely apply for U.S. market approval by 2017. This video includes images from GW... Read more
3 related stories
3d
KIVI Boise
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugsand 55 years old and took Epidiolex in addition to their other anti-epileptic m
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugs
KIVI Boise / Posted 3 days ago
and 55 years old and took Epidiolex in addition to their other anti-epileptic medication. The company that makes the drug, GW Pharmaceuticals, told outlets it will likely apply for U.S. market approval by 2017. This video includes images from GW... Read more
3 related stories
3d
FOX Business
Marijuana Delivers Another Big Win in EpilepsyImage source: GW Pharmaceuticals. Building on its success in treating a rare f
Marijuana Delivers Another Big Win in Epilepsy
FOX Business / Posted 3 days ago
Image source: GW Pharmaceuticals. Building on its success in treating a rare form of epilepsy known as Dravet syndrome earlier this year, marijuana has now shown that it can be used to reduce seizures in patients suffering from Lennox-Gastaut... Read more
3 related stories
3d
FOX Business
Marijuana Delivers Another Big Win in EpilepsyImage source: GW Pharmaceuticals. Continue Reading Below Building on its succ
Marijuana Delivers Another Big Win in Epilepsy
FOX Business / Posted 3 days ago
Image source: GW Pharmaceuticals. Continue Reading Below Building on its success in treating a rare form of epilepsy known as Dravet syndrome earlier this year, marijuana has now shown that it can be used to reduce seizures in patients suffering... Read more
3 related stories
3d
FOX Business
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Todaystocks managed to avoid the downdraft and post substantial gains. Among the bes
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Today
FOX Business / Posted 3 days ago
stocks managed to avoid the downdraft and post substantial gains. Among the best performers were Heartware International , GW Pharmaceuticals , and Randgold Resources . A big buyout lifts Heartware Heartware soared 93% after getting a buyout bid... Read more
3d
FOX Business
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Todaystocks managed to avoid the downdraft and post substantial gains. Among the bes
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Today
FOX Business / Posted 3 days ago
stocks managed to avoid the downdraft and post substantial gains. Among the best performers were Heartware International , GW Pharmaceuticals , and Randgold Resources . A big buyout lifts Heartware Heartware soared 93% after getting a buyout bid... Read more
3d
Fortune
Here's Why This Marijuana Drug Company's Stock Is Soaring TodayGW Pharmaceuticals gwph could be on its way to eventually winning the first U.S
Here's Why This Marijuana Drug Company's Stock Is Soaring Today
Fortune / Posted 3 days ago
GW Pharmaceuticals gwph could be on its way to eventually winning the first U.S. approval for a marijuana-based prescription drug. The U.K.-based biopharma on Monday unveiled more data finding that its investigational therapy Epidiolex, which is... Read more
3d
FOX Business
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit SellImage source: Getty Images. What: While the broader markets are heading south
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit Sell
FOX Business / Posted 3 days ago
Image source: Getty Images. What: While the broader markets are heading south today on the Brexit vote, shares of GW Pharmaceuticals gained as much as 12.4% on a positive clinical update for its marijuana-derived epilepsy medicine Epidiolex.... Read more
3 related stories
3d
FOX Business
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit SellImages. Continue Reading Below What: While the broader markets are heading so
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit Sell
FOX Business / Posted 3 days ago
Images. Continue Reading Below What: While the broader markets are heading south today on the Brexit vote, shares of GW Pharmaceuticals gained as much as 12.4% on a positive clinical update for its marijuana-derived epilepsy medicine... Read more
3 related stories
3d
WTAE-TV Pittsburgh
(REPLAY) Chronicle: Compassion and CannabisSYDNEY HAS HER BROTHER, WHO HAS HAD A COUPLE OF SEIZURES, BUT IS DOING FINE. PA
(REPLAY) Chronicle: Compassion and Cannabis
WTAE-TV Pittsburgh / Posted 3 days ago
SYDNEY HAS HER BROTHER, WHO HAS HAD A COUPLE OF SEIZURES, BUT IS DOING FINE. PAUL REVEALS THAT HE AND HIS LIFE. CB OIL FROM GW PHARMACEUTICALS, A BRITISH COMPANY. OIL. RESPONSIBLE FOR MOST OF THE MARIJUANA HIGH. >> WE HAVE BEEN HOLD THAT THE TO 1... Read more
3d
Business Insider
A drug derived from marijuana is working for people with a rare form of epilepsy — and the company’s stock is taking off22%. Lennox-Gastaut Syndrome is a rare form of childhood-onset epilepsy that's
A drug derived from marijuana is working for people with a rare form of epilepsy — and the company’s stock is taking off
Business Insider / Posted 3 days ago
22%. Lennox-Gastaut Syndrome is a rare form of childhood-onset epilepsy that's associated with multiple types of seizures. GW Pharmaceuticals, the company developing Epidiolex, was up more than 10% on Monday. If approved, it would be the first of... Read more
3 related stories
5d
FOX Business
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Awaythat marijuana could indeed have benefits. A liquid cannabidiol-based formulati
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Away
FOX Business / Posted 5 days ago
that marijuana could indeed have benefits. A liquid cannabidiol-based formulation currently in late-stage studies by GW Pharmaceuticals , known as Epidiolex, has helped to reduce seizure frequency in patients with Dravet syndrome, a type of... Read more
5d
FOX Business
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Awaythat marijuana could indeed have benefits. A liquid cannabidiol-based formulati
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Away
FOX Business / Posted 5 days ago
that marijuana could indeed have benefits. A liquid cannabidiol-based formulation currently in late-stage studies by GW Pharmaceuticals , known as Epidiolex, has helped to reduce seizure frequency in patients with Dravet syndrome, a type of... Read more
8d
FOX Business
3 Stocks Wall Street Loves That You Should AvoidWilliamsOne stock that Wall Street fancies that I would strongly recommend avoi
3 Stocks Wall Street Loves That You Should Avoid
FOX Business / Posted 8 days ago
WilliamsOne stock that Wall Street fancies that I would strongly recommend avoiding is cannabinoid-based drug developer GW Pharmaceuticals . According to data provided by Thompson/First Call, two analysts currently rate the company a "strong... Read more
8d
FOX Business
3 Stocks Wall Street Loves That You Should AvoidWilliamsOne stock that Wall Street fancies that I would strongly recommend avoi
3 Stocks Wall Street Loves That You Should Avoid
FOX Business / Posted 8 days ago
WilliamsOne stock that Wall Street fancies that I would strongly recommend avoiding is cannabinoid-based drug developer GW Pharmaceuticals . According to data provided by Thompson/First Call, two analysts currently rate the company a "strong... Read more
11d
FOX Business
Forget the United States -- This Country Could Easily Represent Marijuana's Biggest Opportunityon the act by researching cannabinoids designed to interact with the cannabinoi
Forget the United States -- This Country Could Easily Represent Marijuana's Biggest Opportunity
FOX Business / Posted 11 days ago
on the act by researching cannabinoids designed to interact with the cannabinoid receptor system located within our bodies. GW Pharmaceuticals' Epidiolex is a great example. In a phase 3 study reported in March, GW Pharmaceuticals announced that... Read more
11d
FOX Business
Forget the United States -- This Country Could Easily Represent Marijuana's Biggest Opportunityon the act by researching cannabinoids designed to interact with the cannabinoi
Forget the United States -- This Country Could Easily Represent Marijuana's Biggest Opportunity
FOX Business / Posted 11 days ago
on the act by researching cannabinoids designed to interact with the cannabinoid receptor system located within our bodies. GW Pharmaceuticals' Epidiolex is a great example. In a phase 3 study reported in March, GW Pharmaceuticals announced that... Read more
13d
CNBC
Avoid these stocks like the plague next weekthinking much longer term," Farrell said. In the Lightning Round, Cramer gave
Avoid these stocks like the plague next week
CNBC / Posted 13 days ago
thinking much longer term," Farrell said. In the Lightning Round, Cramer gave his take on a few caller favorite stocks: GW Pharmaceuticals: "I'm saying that it's a big speculative stock, and I do believe that medical marijuana needs to be... Read more
19d
FOX Business
Say Hello to the 25th and Newest State to Legalize Medical Marijuanaseen what seem to be discernable positives for cannabis, or its cannabinoids, i
Say Hello to the 25th and Newest State to Legalize Medical Marijuana
FOX Business / Posted 19 days ago
seen what seem to be discernable positives for cannabis, or its cannabinoids, in treating sick patients. Image source: GW Pharmaceuticals. The most notable and effective treatment just might be GW Pharmaceuticals' experimental liquid medicine,... Read more
19d
FOX Business
Say Hello to the 25th and Newest State to Legalize Medical Marijuanaseen what seem to be discernable positives for cannabis, or its cannabinoids, i
Say Hello to the 25th and Newest State to Legalize Medical Marijuana
FOX Business / Posted 19 days ago
seen what seem to be discernable positives for cannabis, or its cannabinoids, in treating sick patients. Image source: GW Pharmaceuticals. Continue Reading Below The most notable and effective treatment just might be GW Pharmaceuticals'... Read more
23d
The Mercury News
Lafayette: Panelists aim to cut through medical marijuana hazetip the tide of federal government opposition. "Acceptance is about to change o
Lafayette: Panelists aim to cut through medical marijuana haze
The Mercury News / Posted 23 days ago
tip the tide of federal government opposition. "Acceptance is about to change on the federal level," Theisen predicts. "GW Pharmaceuticals out of the U.K, they're in Phase 3 clinical trial of epidiolex, a drug used to control seizures. They've... Read more
26d
FOX Business
Why This Marijuana Stock Jumped 19% in MayImage source: GW Pharmaceuticals plc. What: Ahead of important data that may a
Why This Marijuana Stock Jumped 19% in May
FOX Business / Posted 26 days ago
Image source: GW Pharmaceuticals plc. What: Ahead of important data that may add conviction to the use of marijuana to treat epilepsy patients, shares in GW Pharmaceuticals plc soared 18.7% last month,according toS&P Global Market Intelligence. So... Read more
26d
FOX Business
Why This Marijuana Stock Jumped 19% in MayImage source: GW Pharmaceuticals plc. Continue Reading Below What: Ahead of i
Why This Marijuana Stock Jumped 19% in May
FOX Business / Posted 26 days ago
Image source: GW Pharmaceuticals plc. Continue Reading Below What: Ahead of important data that may add conviction to the use of marijuana to treat epilepsy patients, shares in GW Pharmaceuticals plc soared 18.7% last month,according toS&P Global... Read more
29d
The Sacramento Bee
Chapter 2: Hope and relief found in the hillsThe researchers were testing a 99 percent pure CBD formula called Epidiolex. It
Chapter 2: Hope and relief found in the hills
The Sacramento Bee / Posted 29 days ago
The researchers were testing a 99 percent pure CBD formula called Epidiolex. It was being developed by a British company, GW Pharmaceuticals – the first step in a long process to evaluate it for potential approval for prescription use. A broader... Read more
2 related stories
m
FOX Business
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hillcause. In one corner we have patients and some physicians who see discernable t
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hill
FOX Business / Posted 1 months ago
cause. In one corner we have patients and some physicians who see discernable treatment benefits from medical marijuana. GW Pharmaceuticals , a predominantly clinical-stage drug developer that's focused on creating medicines derived from... Read more
m
FOX Business
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hillcause. In one corner we have patients and some physicians who see discernable t
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hill
FOX Business / Posted 1 months ago
cause. In one corner we have patients and some physicians who see discernable treatment benefits from medical marijuana. GW Pharmaceuticals , a predominantly clinical-stage drug developer that's focused on creating medicines derived from... Read more
m
CNBC
My speculative play on potstocks, it's under $300 million [market cap] but I know that things are doing r
My speculative play on pot
CNBC / Posted 1 months ago
stocks, it's under $300 million [market cap] but I know that things are doing really well there. I would hold on." GW Pharmaceuticals: "GW Pharma is incredibly speculative. This is a play on the ultimate legalization of pure marijuana as a... Read more

People in this news